Skip to search.
 TSX Up 0.38% TSX Ventures Down 0.06%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
2.60 Down 0.05(1.89%) 4:00PM EST
Prev Close:2.65
Open:2.60
Bid:2.45 x 600
Ask:2.75 x 9500
1y Target Est:8.00
Beta:2.4046
Earnings Date:Feb 20 - Feb 24 (Est.)
Day's Range:2.50 - 2.65
52wk Range:2.13 - 10.18
Volume:359,345
Avg Vol (3m):433,094
Market Cap:137.60M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.54
Quarterly EPS Est (Dec-16) :-0.37
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target RNAs to treat a range of diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback